IP Library › Granted Patent US 8,626,269
Granted Patent B2
US 8,626,269 · App. 13/155,628 · Granted Jan 7, 2014

Fibrous marker and intracorporeal delivery thereof

Inventors: Michael L. Jones (San Clemente, CA); Paul Lubock (Laguna Niguel, CA); Lloyd H. Malchow (San Juan Capistrano, CA)
Assignee: Senorx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,626,269
App. No.
13/155,628
Granted
Jan 7, 2014
Kind
B2
Abstract

An intracorporeal marker includes a fibrous unitary marker body having bioabsorbable fibers compressed into a compressed configuration, and bound in the compressed configuration by a polymer binding agent. The intracorporeal marker may be incorporated into an intracorporeal marker delivery device having a delivery cannula which has a distal tip, an inner lumen and a discharge opening in communication with the inner lumen. The compression and binding occur prior to insertion of the fibrous unitary marker body into the inner lumen of the delivery cannula. The fibrous unitary marker body is slidably disposed within and pushable through the inner lumen of the elongated delivery cannula proximal to the discharge opening.

Claims (14)

1. An intracorporeal marker comprising a fibrous unitary marker body having bioabsorbable fibers compressed into a compressed configuration, and bound in the compressed configuration by a polymer binding agent, wherein the fibrous unitary marker body comprises a core of bioabsorbable felt surrounded by a bioabsorbable fabric jacket.

2. The intracorporeal marker of claim 1 , wherein the bioabsorbable fibers comprise a bioabsorbable material selected from the group consisting of cellulose, polylactic acid, a copolymer of polylactic acid and glycolic acid, and polycaprolactone and wherein the cellulose is oxidized, regenerated cellulose.

3. The intracorporeal marker of claim 1 , wherein the bioabsorbable fibers swell in the presence of body fluids or other water based fluids.

4. An intracorporeal marker comprising a fibrous unitary marker body having bioabsorbable fibers compressed into a compressed configuration, and bound in the compressed configuration by a polymer binding agent, wherein the bioabsorbable fibers comprise a woven fabric.

5. An intracorporeal marker comprising a fibrous unitary marker body having bioabsorbable fibers compressed into a compressed configuration, and bound in the compressed configuration by a polymer binding agent, wherein the bioabsorbable fibers comprise a felt fabric.

6. An intracorporeal marker comprising:

a fibrous unitary marker body configured as a roll of bioabsorbable fiber material having at least one wrap; and

a core of compressed bioabsorbable fibers bound in the compressed configuration by a polymer binding agent, the core being interposed within the roll of bioabsorbable fiber material.

7. The intracorporeal marker of claim 6 , wherein the fibrous unitary marker body includes at least one bioactive component selected from the group consisting of therapeutic and diagnostic agents incorporated therein.

8. An intracorporeal marker delivery device, comprising:

a delivery cannula which has a distal tip, an inner lumen and a discharge opening in communication with the inner lumen; and

a fibrous unitary marker body comprising bioabsorbable fibers which is compressed into a compressed configuration and bound in the compressed configuration by a binding agent prior to insertion into the inner lumen of the delivery cannula, the fibrous unitary marker body being slidably disposed within and pushable through the inner lumen of the elongated delivery cannula proximal to the discharge opening, further comprising

a short term ultrasonically detectable marker slidably disposed within the inner lumen of the delivery cannula proximal to the discharge opening, the fibrous unitary marker body being disposed within the inner lumen of the cannula proximal to the short term ultrasonically detectable marker.

9. The intracorporeal marker delivery device of claim 8 , wherein the bioabsorbable fibers expand upon contact with body fluid or other water based fluid.

Continuity (2)
Continuation 10444770 · May 23, 2003
Related Publication 20110237943A1 · Sep 29, 2011